VYVANSE

Identification of Vyvanse

No description

Google image searchProduct monograph

Active ingredient

lisdexamfetamine dimesylate, 50 MG

DIN: 02490269

Dosage form(s): TABLET (CHEWABLE)

Route(s) of administration: ORAL

Schedule: Schedule G (CDSA I)

Company: TAKEDA CANADA INC

Date: 15-DEC-2021

ATC:

Reference brand drug: Vyvanse

Search on Google

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find vyvanse photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.